• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Ovarian Epithelial Cancer

Ovarian Epithelial Cancer - 24 Studies Found

Completed : Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer
:
  • Recurrent Ovarian Epithelial Cancer
  • Recurrent Primary Peritonea
    : 2004-11-09
    :
    • Drug: gemcitabine hydrochloride

Completed : Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma
: Ovarian Carcinoma
: 2014-11-19
Not yet recruiting : Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.
: Epithelial Ovarian Cancer
: 2017-05-13
: Diagnostic Test: methylation markers screening ctDNA extraction from plasma samples;bisulfite-treated DN
Completed : FES-PET to Determine ER-expression in Epithelial Ovarian Cancer
: Epithelial Ovarian Cancer
: 2011-09-20
: Other: FES-PET Patients undergo FES-PET prior to obtaining histology
Terminated : Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy
: Ovarian Carcinoma
: 2010-08-01
: Drug: Cytophosphan, Celecoxib, Methotrexate Metronomic Che
Completed : Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma
: Ovarian Carcinoma
: 2008-07-23
: Dietary Supplement: Double-Brewed Green Tea liquid, 4 celsius; 500 mL ID, 3 hours after meals and 1 hour
Completed : Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs.
: Epithelial Ovarian Cancer
: 2014-12-11
: Other: Gynecological consultation
Completed : Safety of Active Immunotherapy in Subjects With Ovarian Cancer
: Ovarian Epithelial Cancer
: 2011-09-14
:
  • Biological: Procure The IMP (I

Completed : REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression
: Ovarian Carcinoma
: 2015-07-29
:
  • Drug: Tamoxifen Tamoxifen: 40

Completed : Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type
: Epithelial Ovarian Cancer
: 2009-03-12
:
  • Drug: Pegylated liposomal doxorubicin

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.